Re-introducing the same chemotherapy after exposure to anti-PD-1 therapy

Cytotoxic chemotherapy after exposure to nivolumab (nivo), an anti-programmed death-1 (PD-1) antibody, has been associated with good response compared with historical data in various cancers including head and neck squamous cell carcinoma (HNSCC). In a previous report, different chemotherapy regimen...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International cancer conference journal 2019-04, Vol.8 (2), p.86-88
Hauptverfasser:	Koyama, Takashi, Nomura, Motoo, Keitaro, Doi, Tateya, Ichiro, Muto, Manabu
Format:	Artikel
Sprache:	eng
Schlagworte:	Acne Antibodies Apoptosis Cancer therapies Case Report Chemotherapy Conflicts of interest Cytotoxicity Drug dosages Ethics Head & neck cancer Head and neck carcinoma Immunotherapy Lung cancer Medical prognosis Medicine Medicine & Public Health Metastasis Oncology Patients PD-1 protein Squamous cell carcinoma Surgical Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!